Cyclicality — a non-residential construction / data-center capex downturn hits a name carrying 2.5× net leverage
One-line thesis. JCI has become a cleaner, higher-margin pure-play buildings company — thermal management, controls, fire/security, and increasingly data-center HVAC — and a new CEO is running a margin-expansion playbook that is showing up (Q2 FY26 adjusted EPS +45%, orders +30% organic, record $20B backlog). But it is a mid-single-digit organic grower trading around fair value with real construction-cycle sensitivity, so the honest verdict is a Tactical buy on the margin/backlog momentum, not a core compounder.
◆ Synthos call — WatchJCI is a business we want at a price we don't have — it becomes a Buy below ~$134; until then, do nothing.
Downside Risk (lower = safer)
5/10 · Moderate
Net-debt/EBITDA 2.5× and beta 1.34 (cyclical) offset by low 25× P/E and record $20B backlog; construction-cycle exposure is the real risk.
Growth Quality
6/10 · High
~16% forward EPS CAGR on margin expansion + buybacks, but only ~7% revenue CAGR; ROE 25% flattered by leverage & buyback.
Exponential Potential
4/10 · Moderate
Data-center HVAC is a genuine tailwind, but a mid-single-digit organic grower re-rating on margins — not a volume exponential.
⚖ Reverse-DCF cross-checkMarket-implied growth ≈ 34%/yrTo justify today’s $141, earnings would have to compound roughly 34% a year for 10 years (9% discount rate). Analysts forecast ~20%/yr, so the market is pricing in MORE than what the Street expects.What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.
In plain English
Johnson Controls makes the heating, air-conditioning, controls, fire-safety, and security systems that run big buildings — office towers, hospitals, factories, and, increasingly, the data centers that power AI. Think of it as the company that keeps large buildings cool, safe, and efficient. It recently sold off its side businesses to focus only on this.
Is the stock cheap or expensive? It's roughly fairly priced — about 25 times last year's earnings, which is normal for a solid industrial company. It's not a bargain, but it's not wildly expensive either. Our verdict is a Tactical buy: worth owning for the current momentum (a new boss is squeezing out more profit and the order book just hit a record), but this is a company whose fortunes rise and fall with the building-construction cycle, so keep the position modest.
Here's what our three scores mean in everyday terms:
Downside Risk 5/10 (middle of the road). Reasonable valuation and a record order backlog, but the company carries a fair amount of debt and its business swings with the economy.
Growth Quality 6/10 (decent). Profits are growing at a healthy mid-teens pace — but a lot of that comes from cost-cutting and share buybacks, not from selling a lot more product.
Exponential Potential 4/10 (low-moderate). Data centers are a real tailwind, but this is a steady grower, not a company about to double its sales.
The one big worry: JCI's customers build things — offices, factories, data centers. If a recession or an AI-spending pullback slows construction, orders dry up quickly, and the company owes enough money that a slowdown would sting more than for a debt-free peer.
Note on coverage: No outside expert in Synthos's knowledge base covers JCI. This write-up is built entirely from the company's financial filings, Wall Street estimates, and management's own guidance — not from independent expert conviction. We say so up front.
Solid = price · dashed = 50-day average · dotted = 200-day average · amber = 52-week high/low. Price above both averages is an uptrend.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Blue crossing above amber (bars flip green) = momentum turning up; below (bars red) = turning down. Bar height = the size of that gap.
Relative performance vs S&P 500 & its sector (XLB (sector)), set to 100 a year ago
Solid = JCI · dashed = S&P 500 · dotted = XLB (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
Price$140.76
Market cap$86B
P/E trailing6×
P/E FY26E / FY27E29× / 24×
EV / Sales3.9×
EV / EBITDA26.6×
Gross margin36.6%
Net margin14.5%
Dividend yield1.14%
Beta1.337
52-wk range$103 – $148
RSI(14)46
50 / 200-DMA$142 / $127
12-mo return+34% (SPY +21%)
Street target$156 ($130–$180)
Analyst grades28 Buy · 17 Hold · 0 Sell
FMP ratingB+
Next earnings2026-08-05
What the experts actually said 0 traceable claims on JCI · showing the highest-conviction voices
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
1. What it is
Johnson Controls International plc (NYSE: JCI) is a ~140-year-old global buildings-technology company, now headquartered in Cork, Ireland (an Irish domicile from the 2016 Tyco merger). After a multi-year portfolio cleanup — exiting the Power Solutions (automotive batteries) business years ago and, most recently, divesting its residential & light-commercial HVAC and the Global Products segment — it is today a focused commercial buildings company: HVAC and applied cooling, building automation/controls, fire detection and suppression, and integrated security, sold increasingly as solutions + recurring services. Fiscal year ends September 30. A new CEO, Joakim Weidemanis, is running an operational-excellence / "Business System" margin playbook.
Revenue mix (FY2025, from FMP segmentation):
By region-segment: Building Solutions North America $15.83B (67%) · EMEA/LA $4.97B (21%) · Asia Pacific $2.80B (12%). (The historical "Global Products" line — $5.1B in FY24 — has effectively disappeared from FY25 continuing-ops reporting as that business was divested; this is why FY25 continuing revenue looks flat despite strong organic growth.)
By geography (partial FMP tag): United States tagged at $13.3B in FY25; the US is the clear majority of revenue — a domestic-construction and data-center exposure that is both the growth engine and the cyclical risk (§11).
The strategic story management keeps pushing: convert sustained demand (data centers, healthcare, pharma, advanced manufacturing) into margin expansion and a record backlog, while a leaner corporate structure strips out stranded costs from the divestitures.
2. The expert thesis — (none in the Synthos KB)
There is no expert coverage of JCI in the Synthos knowledge base.total_claims = 0, net_bullish_voices = 0. No independent analyst, fund manager, or operator in our tracked panel has a signed, traceable view on this name.
That means this deep dive carries no conviction-track weight. The verdict is fundamentals- and quant-driven only: FMP financials, the analyst-estimate consensus, management's self-interested guidance (half-weighted, §9), and Synthos's own scenario model. We will not manufacture conviction we do not have — per the house standard, we cite only claim_ids that exist, and here there are none. Treat the call accordingly: it is an honest read of the numbers, not a chorus of expert voices.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):
Score
0–10
The read
Downside Risk(lower = safer)
5 · Moderate
25× trailing / 24× FY27E is reasonable and the record $20B backlog gives revenue visibility, but net-debt/EBITDA 2.5× and beta 1.34 on a cyclical construction end-market cut the other way.
Growth Quality
6 · Decent
~16% forward EPS CAGR (FY26→FY30E) with expanding margins and 25% ROE — but revenue CAGR is only ~7%, and the EPS growth leans on margin + buyback, so quality is good-not-elite.
Exponential Potential
4 · Low-Moderate
Data-center HVAC is a genuine secular tailwind and orders/backlog are inflecting, but this is a mid-single-digit organic grower re-rating on execution, not an accelerating volume story.
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is by definition the expected path, so a weighted blend would just restate it with false precision. The cases bound the range; the scores above summarize them.
Case
Key assumptions
Fair value
Bull
Data-center demand stays hot, backlog converts at high margins, Business System drives operating leverage above the 50% guide; FY28E EPS beats to ~$7.0 (vs $6.63 cons), the market pays a premium ~25× for a de-risked, services-heavy compounder.
~$180 (+28%)
Base(our anchor)
Guidance roughly holds — 6% organic growth, 50% operating leverage, FY26 adj EPS ~$4.85–$4.89, building toward FY27E $5.75 / FY28E $6.63; a steady industrial earns ~23–24× forward on ~$6.4 of blended near-term power.
~$152 (+8%)
Bear
Non-residential construction and/or AI-data-center capex rolls over; orders decelerate, backlog quality is questioned, margin gains stall. FY27E EPS misses to ~$5.0; multiple de-rates to a cyclical ~17–21×.
~$105 (−25%)
Synthos fair value = the base case, ~$152 (+8%), with the full $105–$180 span as the honest range. Our base sits right on top of the Street's $156.4 consensus — this is a name where we do not see a large edge either way; the asymmetry is modest and momentum-dependent, which is exactly why the verdict is Tactical, not Core. This is a tracked call — the Forecaster Scorecard grades it once it matures.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). JCI is neither a pure compounder nor an exponential — it is a cyclical industrial in the middle of a self-help re-rating:
Forward growth: revenue CAGR FY25→FY30E ~7.4% ($23.6B → $33.7B); EPS CAGR FY26→FY30E ~15.7% ($4.89 → $8.77). The gap between the two tells the story — earnings grow ~2× faster than sales because of margin expansion + buybacks, not volume.
Acceleration (the 2nd derivative): organic revenue growth is running a steady ~6% (management's guide), not accelerating. What is inflecting is orders (+30% organic in Q2 FY26) and backlog ($20B, +26%) — a real leading indicator, but one tied to the data-center build cycle rather than a structural step-change in the core.
Room to run: at $85.9B market cap in a large but mature global buildings-controls TAM, there is no law-of-large-numbers wall — but there is also no small-cap runway. A 3× from here would require both sustained data-center capex and a durable margin re-rate; plausible in the bull case, not the base.
Reinvestment runway: capex is light (~$434M, <2% of revenue) and FCF conversion is the swing factor — FY25 reported FCF was noisy at ~$965M (divestiture drag), but management guides ~100% adjusted FCF conversion, which if delivered funds buybacks that flatter EPS.
Exponential Potential: Low-Moderate (4/10). Own JCI for a margin-and-backlog re-rating with a data-center kicker, not for exponential top-line growth. The honest framing is why this is a tactical/cyclical satellite, not a core exponential.
Revenue: FY25 continuing $23.60B, +2.8% reported over FY24 $22.95B — but this understates underlying momentum because the Global Products divestiture pulled ~$5B out of the base; organic growth is running ~6%. Q2 FY26 sales $6.14B, +8% reported / +6% organic.
Margins: gross 36.6% TTM, EBITDA margin ~14.6% TTM, net ~14.5% TTM (flattered by a large discontinued-operations gain in FY25). The real signal is segment margin expansion — Americas adj EBITA margin +100bp to 19.5%, EMEA +370bp, APAC +350bp in Q2 FY26.
Earnings: FY25 GAAP net income $1.72B from continuing ops (plus $1.79B discontinued-ops gain); TTM EPS $2.64 GAAP. Management's adjusted FY26 EPS guide is $4.85 — note the wide GAAP-vs-adjusted gap driven by transformation/separation costs, a quality flag to watch.
Cash flow: FY25 operating CF $1.40B, capex −$434M, reported FCF ~$965M (depressed by divestiture and working-capital noise); Q2 FY26 adjusted FCF $526M. FCF yield is optically low (~1.6% TTM) — this is a watch item, not yet a clean compounder cash profile.
Balance sheet: total debt $11.19B, net debt $10.81B, net-debt/EBITDA ~2.48× — investment-grade (letter rating B+) but meaningfully levered for a cyclical. Interest coverage ~22× is comfortable at current EBITDA.
6. Valuation — priced in or room?
JCI is roughly fairly valued, not cheap and not egregious. Trailing 25× P/E, 26.6× EV/EBITDA, 3.9× EV/sales. On forward estimates the multiple compresses as earnings grow: 29× FY26E → 24× FY27E → 18× FY29E → 16× FY30E — the classic industrial "grow into the multiple" setup, if the margin story delivers. The PEG on trailing EPS growth is optically low (~0.5×) but the forward PEG is ~1.4× — i.e. the easy re-rating may already be partly done. Street targets (context): consensus $156.4, high $180, low $130; 28 Buy / 17 Hold / 0 Sell — a constructive-but-not-euphoric Street. Our base FV of ~$152 deliberately sits just under consensus because we take the cyclicality and 2.5× leverage more seriously than a simple forward-multiple extrapolation. Not a value buy; a fairly-priced self-help industrial where the edge is momentum, not a valuation gap.
7. Technicals (from the FMP tech block)
Trend:constructive. $140.76 sits above the 200-DMA ($127.3) but just below the 50-DMA ($142.0) — a mild near-term consolidation inside a longer uptrend (200-DMA rising, price well above it).
Location:−5.0% off the 52-week high ($148.21), +36% off the 52-week low ($103.24) — closer to the top of its range than the bottom, modest drawdown (max −5% from peak).
Momentum: RSI(14) 46 — neutral, neither overbought nor oversold; MACD marginally positive (+0.37). No stretched-entry signal; if anything a cooler, lower-risk entry zone than a name pinned at highs.
Relative strength: JCI +34.5% 12-mo vs SPY +20.6% (outperforming the market) but +4.5% 3-mo vs SPY +13.7% and QQQ +22.0% (lagging recently). A leader over 12 months taking a breather over the last quarter.
Read: technicals are neutral-to-constructive — a healthy pullback within an uptrend, RSI reset to neutral. No technical reason to chase; a hold of the 50-DMA (~$142) or a dip toward the rising 200-DMA (~$127) would be lower-risk add zones.
8. Moat & competitive position
JCI's moat is moderate and installed-base-driven, not a wide structural moat. Its edge is (1) a large installed base of building systems that generates recurring, higher-margin service and controls revenue with switching costs; (2) scale and breadth across HVAC + fire + security + controls, letting it bid integrated "smart building" solutions; and (3) a timely data-center position — applied cooling and thermal management for hyperscale/AI buildings, the segment driving the +30% orders. The weaknesses: the core is a competitive, cyclical, capital-goods market with capable rivals, and the moat depends on execution (the Business System margin story) rather than a durable pricing monopoly.
Peer set (FMP, market cap): Trane Technologies $105.7B (the closest and higher-quality HVAC comp), Carrier Global $58.2B (direct HVAC spin-comp), Vertiv $115.4B (data-center thermal/power — the hot comp), Emerson $77.9B, Illinois Tool Works $78.5B, Quanta Services $100.3B, TransDigm $75.4B, Cintas $72.6B, Waste Management $92.5B, Thomson Reuters $38.9B. Within HVAC, Trane and Vertiv command higher multiples and cleaner growth narratives — JCI is the "self-help / re-rating" name in the group, not the premium leader.
9. Management, capital allocation & guidance
Capital allocation: aggressive buybacks (FY25 repurchased ~$5.99B of stock — a large number inflated by returning divestiture proceeds), a dividend ($1.60/yr, ~1.1% yield, ~28% payout), and light capex. The buyback is doing real work in the EPS growth rate — a quality caveat: some of the "growth" is share-count reduction, not operating gains.
Insider activity: routine officer sales in the sampled window (VP Americas Grabowski selling small lots at $145–146 in May–June 2026; a VP exercising and selling options in May) plus a director share award — normal diversification, no alarming discretionary cluster.
Management's own guidance (half-weighted — their self-interested words): In the 2026-05-06 Q2 FY26 earnings release (SEC 8-K Item 2.02, verified real), management raised FY26 guidance: full-year organic sales growth ~6% (up from mid-single digits), operating leverage ~50%, adjusted EPS $4.85 (raised from $4.70), and ~100% adjusted free-cash-flow conversion. For Q3 FY26 they guide 6% organic growth, 50% operating leverage, adjusted EPS $1.28. CEO Weidemanis framed it as "converting sustained demand into consistent growth, margin expansion, and 45% adjusted EPS growth," citing data-center strength and a record $20B backlog. Treat as management's own book, half-weighted — but note the guide was raised, and Q2 actuals ($1.19 adj vs $1.12 Street) beat, which lends it some credibility.
10. Catalysts & what to watch
Next earnings: 2026-08-04 (Q3 FY26; Street EPS $1.32, management guide $1.28, revenue ~$6.46B). Key lines: organic growth, orders/backlog trajectory, and segment margin expansion.
Data-center order momentum: the +30% organic orders and $20B backlog are the single biggest swing factor — watch for any deceleration.
Margin delivery: the Business System / operating-leverage story (50% guide) is the crux of the EPS re-rating — confirmation or disappointment moves the stock.
FCF conversion: the ~100% adjusted conversion guide vs the noisy reported FCF — clean cash conversion would upgrade the quality score.
Divestiture clean-up: stranded-cost removal and the final shape of continuing operations after the Global Products exit.
Thesis tripwires (what would change the call): two consecutive quarters of organic-order deceleration; a stall or reversal in segment margin expansion; adjusted FCF conversion materially below 100%; or a widening GAAP-vs-adjusted EPS gap signaling low earnings quality.
11. Key risks
Cyclicality (structural): non-residential construction and data-center capex are cyclical; a downturn hits orders and backlog quickly, and JCI carries 2.5× net leverage and a 1.34 beta into any such slowdown.
Earnings quality / adjustments: a wide gap between GAAP (TTM EPS $2.64) and adjusted (FY26 guide $4.85) EPS, plus transformation/separation add-backs — watch that "adjusted" doesn't paper over recurring costs.
Growth leans on buybacks: a meaningful slice of forward EPS growth is share-count reduction, not organic operating gains.
Execution dependence: the whole re-rating rests on management delivering the Business System margin playbook — a new CEO with an unproven-at-JCI system.
No expert corroboration: unlike conviction-track names, no independent Synthos-tracked voice validates the thesis — the call rests on numbers and management's own (self-interested) guidance alone.
12. Verdict, position sizing & monitoring
Buy — Tactical. JCI is a cleaner, higher-margin, post-transformation buildings company with genuine momentum — Q2 FY26 adjusted EPS +45%, orders +30% organic, a record $20B backlog, raised guidance, and a data-center tailwind — trading at a reasonable ~24× FY27E with the multiple compressing as earnings grow. But it is a mid-single-digit organic grower at roughly fair value (~$152 base vs $140.76 spot vs $156.4 Street), carrying real construction-cycle and leverage risk, with zero independent expert coverage in our KB. That combination is a tactical buy on momentum, not a core compounder.
Sizing:tactical / cyclical satellite, ~1.5–3% — sized for the construction cycle and for the fact that our edge here is modest and momentum-dependent. Scale in on pullbacks toward the 50-/200-DMA rather than chasing.
Monitoring: re-underwrite on the §10 tripwires; formal re-score each earnings print. This verdict is logged as a tracked Synthos call as of 2026-07-03 at $140.76.
Single biggest risk: cyclicality — a non-residential construction or AI-data-center capex downturn hitting a 2.5×-levered, 1.34-beta name.
Provenance & disclosures
Traceability:0 KB claims, breadth 0 — no expert coverage of JCI in the Synthos knowledge base. This is a fundamentals- and quant-driven note; no conviction is claimed or fabricated.
Data as-of: fundamentals 2026-03-31 (Q2 FY26) · estimates & prices 2026-07-02/03 · management guidance from the 2026-05-06 SEC 8-K earnings release. Forward figures are analyst consensus (FMP) or management guidance, labeled as estimates.
Management caveat: management's raised FY26 guidance ($4.85 adj EPS, 6% organic, 50% operating leverage, ~100% FCF conversion) is management's own book, half-weighted by design.
Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").